Background illustration for clinical trials search

Paid Clinical Trials Plainfield

Discover 2,379 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

for
HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Chicago IL, Baltimore MD, Chapel Hill NC, Dallas TX,
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05029999

Phase 1, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Chicago IL, Cincinnati OH, West Chester OH, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase 1, Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Chicago IL, Milwaukee WI, Iowa City IA, Detroit MI,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase 1, Recruiting

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

for
Bacterial Conjunctivitis
Location: Orland Park IL, Little Rock AR, Greenville SC,
Sponsor: Baxis Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT06911424

Phase 3, Recruiting

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Chicago IL, Little Rock AR, Bryant AR, Decatur GA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT06963034

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

for
Myeloproliferative Neoplasms
Location: Chicago IL, Milwaukee WI
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06291987

Phase 1, Recruiting

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

for
Breast Cancer
Location: Chicago IL, La Jolla CA, Sacramento CA
Sponsor: University of Chicago

Sex: Female

Age: 25+

Code: NCT03729115

Recruiting

A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

for
Squamous Non-small-cell Lung Cancer,
Location: Chicago IL, Fairfax VA, Hackensack NJ, Scottsdale AZ,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT06747585

Phase 1, Phase 2, Recruiting
New

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

for
Ovarian Cancer, Advanced Malignant Solid Tumor
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07389239

Phase 1, Phase 2, Recruiting
New

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

for
Lung Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07782359

Phase 1, Recruiting

Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery

for
Adult Spinal Deformity, Scoliosis, Kyphosis, Sagittal Imbalance
Location: Chicago IL, Pittsburgh PA, Memphis TN, Durham NC,
Sponsor: International Spine Study Group Foundation

Sex: All

Age: 18+

Code: NCT04885244

Recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

for
Androgen Axis Suppression, Prostatectomy, Prostate Cancer
Location: Chicago IL, Kansas City KS, New York NY, Boston MA,
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06274047

Phase 3, Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

for
Buccal Mucosa Squamous Cell Carcinoma,
Location: Chicago IL, Oak Creek WI, New Berlin WI, Milwaukee WI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04333537

Phase 2, Phase 3, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Chicago IL, O'Fallon IL, St Louis MO, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase 3, Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Chicago IL, St Louis MO, Cincinnati OH, Lexington KY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase 3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Chicago IL, Dyer IN, Urbana IL, Springfield IL,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase 3, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Chicago IL, Zion IL, Peoria IL, Decatur IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase 2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Chicago IL, Madison WI, Springfield IL, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Chicago IL, Racine WI, Normal IL, Wauwatosa WI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase 2, Recruiting

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

for
Liver Transplant, Hepatitis C, Chronic Kidney Disease,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT01644903

Recruiting